SADH:XETRA:XETRA-Amundi MSCI USA ESG Leaders UCITS ETF Acc EUR Hedged (EUR)

ETF | Others |

Last Closing

USD 75.05

Change

-0.39 (-0.52)%

Market Cap

USD 0.22B

Volume

1.73K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-07 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
JARI:XETRA Amundi Index Solutions - Amund..

-0.28 (-0.61%)

USD 100.65B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.45 (-0.48%)

USD 84.07B
FRCJ:XETRA UBS MSCI Japan Socially Respon..

-0.09 (-0.38%)

USD 79.79B
AW15:XETRA UBS (Irl) ETF plc - MSCI Japan..

-0.19 (-1.45%)

USD 58.88B
FJPR:XETRA Fidelity Sustainable Research ..

-0.01 (-0.23%)

USD 44.90B
EXX7:XETRA iShares Nikkei 225 UCITS ETF (..

-0.19 (-0.83%)

USD 28.25B
SPYL:XETRA SPDR S&P 500 UCITS ETF USD Acc..

-0.05 (-0.44%)

USD 23.49B
PPFB:XETRA iShares Physical Gold ETC EUR

-0.19 (-0.32%)

USD 20.66B
XDEE:XETRA Xtrackers S&P 500 Equal Weight..

-0.01 (-0.05%)

USD 12.74B
EUN5:XETRA iShares Core Corporate Bond UC..

+0.25 (+0.21%)

USD 12.26B

ETFs Containing SADH:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.78% 37% F 36% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.78% 40% F 38% F
Trailing 12 Months  
Capital Gain 4.66% 69% C- 67% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.66% 70% C- 67% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 10.15% 66% D+ 66% D+
Dividend Return 10.15% 66% D+ 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.19% 50% F 60% D-
Risk Adjusted Return 83.23% 73% C 76% C+
Market Capitalization 0.22B 54% F 41% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike